Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins (Q34378331)

1 August 2017

title

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins (English)

1 reference

1 August 2017

1 reference

Sayuri Taniguchi

1 reference

1 August 2017

Nobuyuki Suzuki

1 reference

1 August 2017

Masami Masuda

1 reference

1 August 2017

Shin-ichi Hisanaga

1 reference

1 August 2017

Takeshi Iwatsubo

1 reference

1 August 2017

Michel Goedert

1 reference

1 August 2017

Masato Hasegawa

1 reference

1 August 2017

language of work or name

English

0 references

publication date

17 December 2004

1 reference

Journal of Biological Chemistry

1 August 2017

published in

1 reference

1 August 2017

volume

280

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

7614-7623

1 reference

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Neurodegenerative tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Tau is a candidate gene for chromosome 17 frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

X-ray diffraction of scrapie prion rods and PrP peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Glutamine repeats and neurodegenerative diseases: molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Shattuck lecture--neurodegenerative diseases and prions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Prion diseases--close to effective therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Ligand-dependent inhibition and reversal of tau filament formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Amphotericin B binds to amyloid fibrils and delays their formation: a therapeutic mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

What does it mean to be natively unfolded?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Porphyrin and phthalocyanine antiscrapie compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408714200

21 January 2018

Identifiers

DOI

10.1074/JBC.M408714200

1 reference

1 August 2017

1 reference